near term catalysts - WISP, NASDAQ, $500MM shelf prospectusI seem to recall reading that the Wisp deal will close in October. should be straight forward as WELL is buying a 53% interest only, and not the entire company, and current management will stay on and run the business as minority owners. I expect WELL will exercise their call option for the remainder of the business once it is scaled.
on a previous conference call this year Hamed said they would be bolstering the 'digital' side of their business prior to the US listing, so i think once Wisp closes we will see the US listing in play and hopefully it can begin trading prior to the end of 2021.
the $500MM shelf prospectus is the REAL wildcard here. I suspect this will be called upon once they get the US listing and the company will use its shares as currency (in USD$) with a capital raise to go after a US player. who they acquire is anybody's guess, but CRH Medical has telegraphed about expanding their business in the past - moving beyond anesthesia for colonoscopies and into anesthesia for other procedures done at ASCs. I know MyHealth is also looking to expand so perhaps these funds could be used to merge with another Canadian player?
in any event, exciting times ahead.
full disclosure - I've purchased more this week and hold over 50,000 shares
GLTA